SCHEMBL6983088

SCHEMBL6983088

COC(=O)[C@@H]1CN(S(=O)(=O)c2ccc(Br)cc2)C[C@H]1c1cccc(C#N)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
SLC6A9 P48067 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA7 P43166 1/20 0.38
ADAM17 P78536 1/20 0.38
TRPV4 Q9HBA0 3/20 0.38
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
HRH3 Q9Y5N1 1/20 0.37
GAA P10253 1/20 0.37
CTSK P43235 1/20 0.36
CCKBR P32239 1/20 0.36
SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983084 1.00 HCRTR1 (0.40) HCRTR1HCRTR2ALDH1A1MAPTSLC6A9
SCHEMBL6983085 1.00 HCRTR1 (0.40) HCRTR1HCRTR2ALDH1A1MAPTSLC6A9
SCHEMBL6984332 0.85 HRH3 (0.43) HCRTR2ALDH1A1SLC6A9SLC6A4SLC6A3
SCHEMBL6984336 0.85 HRH3 (0.43) HCRTR2ALDH1A1SLC6A9SLC6A4SLC6A3
SCHEMBL6984339 0.85 HRH3 (0.43) HCRTR2ALDH1A1SLC6A9SLC6A4SLC6A3
SCHEMBL6984369 0.81 F10 (0.43)
SCHEMBL6984364 0.81 F10 (0.43)
SCHEMBL6979297 0.80 F10 (0.49)
SCHEMBL6979303 0.80 F10 (0.49)
SCHEMBL6979292 0.80 F10 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934265-B1 AMIDINOPHENYL-PYRROLIDINES, -PYRROLINES, AND -ISOXAZOLIDINES AND DERIVATIVES THEREOF BRISTOL MYERS SQUIBB PHARMA CO (US) 2003-01-02 EP disclosed
US-6057342-A INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASE ENZYMES, ESPECIALLY FACTOR XA, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME AS ANTICOAGULANT AGENTS FOR TREATMENT AND PREVENTION OF THROMBOEMBOLIC DISORDERS DUPONT PHARMACEUTICAL CO. (US) 2000-05-02 US disclosed